Table 4.
Intention to treat analysis
| mCPR status treatment group time of measurement | Outcome measures | ||
|---|---|---|---|
| VAS a | ODI b | SF-36 Pain c | |
| (St. Dev.) | (St. Dev.) | (St. Dev.) | |
| Negative on mCPR | |||
| SMT (n = 32) | |||
| Baseline | 58.44 (15.46) | 35.13 (8.55) | 5.56 (1.20) |
| 5-weeks | 37.51 (28.89) | 29.01 (14.66) | 6.98 (1.66) |
| 12-weeks | 43.29 (24.62) | 32.14 (15.77) | 6.41 (1.92) |
| 24-weeks | 47.61 (25.66) | 30.17 (15.69) | 6.60 (2.06) |
| AET (n = 28) | |||
| Baseline | 65.36 (16.78) | 37.04 (12.57) | 5.35 (1.21) |
| 5-weeks | 36.50 (33.77) | 30.15 (17.71) | 6.56 (2.33) |
| 12-weeks | 42.00 (33.57) | 32.91 (20.82) | 6.54 (2.72) |
| 24-weeks | 52.54 (27.24) | 32.71 (18.64) | 6.44 (2.47) |
| Positive on mCPR | |||
| SMT (n = 60) | |||
| Baseline | 61.25 (13.74) | 33.62 (9.60) | 5.78 (1.22) |
| 5-weeks | 34.86 (31.18) | 26.71 (15.06) | 7.10 (2.22) |
| 12-weeks | 40.43 (27.53) | 29.64 (18.30) | 6.57 (2.55) |
| 24-weeks | 38.47 (26.99) | 23.16 (15.74) | 7.51 (2.71) |
| AET (n = 61) | |||
| Baseline | 55.38 (16.64) | 31.44 (10.05) | 6.00 (1.52) |
| 5-weeks | 26.60 (33.48) | 23.73 (17.14) | 7.49 (2.57) |
| 12-weeks | 36.30 (29.64) | 25.94 (19.90) | 7.05 (2.98) |
| 24-weeks | 42.11 (31.77) | 23.52 (18.98) | 7.75 (3.08) |
athe higher the number the higher the reported pain on a 100 point scale.
bthe higher the number the more disability reported due to pain on a 100 point scale.
cthe higher the number the less self-reported pain on the computed SF-36 pain subscale.